Novogene Co., Ltd. (SHA:688315)
China · Delayed Price · Currency is CNY 15.28
-0.36 (-2.30%)
At close: Feb 13, 2026
Novogene Employees
Novogene had 2,190 employees as of June 30, 2025. The number of employees decreased by 12 or -0.54% since the number was reported on December 31, 2024.
Employees
2,190
Change
-12
Growth
-0.54%
Revenue / Employee
986.77K CNY
Profits / Employee
79.57K CNY
Market Cap
6.19B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 2,190 | -12 | -0.54% |
| Dec 31, 2024 | 2,202 | 58 | 2.71% |
| Dec 31, 2023 | 2,144 | -25 | -1.15% |
| Dec 31, 2021 | 2,169 | 178 | 8.94% |
| Dec 31, 2020 | 1,991 | -584 | -22.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Xiangxue Pharmaceutical | 2,769 |
| GemPharmatech | 1,578 |
| PharmaResources (Shanghai) | 1,085 |
| Kexing Biopharm | 971 |
| Lifecome Biochemistry | 898 |
| Shenzhen Weiguang Biological Products | 859 |
| Jiangsu Aidea Pharmaceutical Group | 683 |
| Beijing Konruns Pharmaceutical | 668 |